Cardiac Safety Solutions from BioClinica

With over 25 years of experience in Cardiac Safety monitoring services, BioClinica is a recognized global leader in providing comprehensive services with unrivalled scientific and technical leadership. BioClinica’s medical and scientific team, consisting of board-certified cardiologists and active members of the Cardiac Safety Research Consortium, has strong experience in successfully designing and supporting studies that require cardiac safety monitoring. Our focus goes beyond the single study and across the entire cardiac safety profile of the study compound from Phase I–IV. With experience working alongside the ICH, FDA, EMA, PMDA, and SFDA in the development of regulatory and industry guidelines, BioClinica is the smart choice to support the design and conduct of cardiac safety studies around the globe.